Evaluation of Physical-Chemical and Microbiological Stability of Fluconazole Oral Suspensions for Hospital Use

Authors

  • Camilo Marques D'Amore Laboratório de Controle de Qualidade Farmacêutico, Faculdade de Farmácia - Universidade Federal do Rio Grande do Sul image/svg+xml
    • Elisa de Saldanha Simon Laboratório de Controle de Qualidade Farmacêutico, Faculdade de Farmácia - Universidade Federal do Rio Grande do Sul image/svg+xml
      • Martin Steppe Laboratório de Controle de Qualidade Farmacêutico, Faculdade de Farmácia - Universidade Federal do Rio Grande do Sul image/svg+xml

        DOI:

        https://doi.org/10.22456/2527-2616.103473

        Keywords:

        Fluconazole, Analytical Method Suitability, Formulation Development, Formulation Stability

        Abstract

        Fluconazole is an important drug in the treatment of cutaneous and systemic mycoses. The Hospital de Clínicas de Porto Alegre performs a derivation of fluconazole capsules to obtain an oral liquid formulation that is easily administered and whose dose can be adjusted. In order to replace the derivation for a formulation produced from an active pharmaceutical ingredient, this study sought to develop a liquid oral formulation, evaluate its physical chemical and microbiological stability and demonstrate suitability of the analytical method for the formulation assay. Seven different formulations of pharmaceutical suspension form were produced and evaluated for pH, viscosity, sedimentation volume and assay. The analytical method by High Performance Liquid Chromatography was demonstrated. Two most promising formulations were manipulated in the Farmácia Semi-Industrial do Hospital de Clínicas de Porto Alegre and stored in amber PET bottles under three different conditions: room temperature, under refrigeration (2 to 8 ºC) and in an oven (40 ° C). Samples were collected after 0, 7 and 14 days to evaluate physical-chemical stability, assay, pH and macroscopic aspects. Samples were collected after 0 and 21 days to evaluate microbiological stability. It was possible to demonstrate stability for one of the formulations for a 14-day period. Throughout the study, the chosen formulation presented adequate quantification of fluconazole, constant pH, no organoleptic changes and no microbial growth. The results suggest the incorporation of a new formulation for fluconazole to the Farmacia Semi-Industrial portfolio).

        Downloads

        Download data is not yet available.

        References

        Castro G, et al. Time-of-flight mass spectrometry assessment of fluconazole and climbazole UV and UV/H2O2 degradability: Kinetics study and transformation products elucidation. Water Research, 2015; 681-690.

        Bourichia H, et al. Solid-state characterization and impurities determination of fluconazol generic products marketed in Morocco. Journal of Pharmaceutical Analysis. 2012; 412-421.

        Cyr TD, et al. Spectral characterization of fluconazole. Journal of Pharmaceutical and Biomedical Analysis. 1996; 247-255.

        Dentinger PJ, Swenson, C. F. Stability of Reconstituted Fluconazole Oral Suspension in Plastic. The Annals of Pharmacotherapy. 2009; 285- 289.

        Hurtado FK, et al. Microbiological Assay and HPLC Method for the Determination of Fluconazole in Pharmaceutical Injectable Formulations. Latin American Journal of Pharmacy. 2008; 224-228.

        Sweetman, SC. Martindale: The Complete Drug Reference. 36. ed. London: Rps Publishing; 2009.

        Ayers MV et al.. Evaluation of the stability of Vigabatrin in hospitalar extemporaneous formulations. Drug Analytical Research, 2019; 51- 60.

        BRASIL. Resolução RDC n° 318, de 06 de novembro de 2019. Estabelece os critérios para a realização de Estudos de Estabilidade de insumos farmacêuticos ativos e medicamentos, exceto biológicos, e dá outras providências. Diário Oficial União. 07 nov 2019.

        Gobetti C. Avaliação da Estabilidade de Derivação Farmacêutica Hospitalar de Tizanidina. Porto Alegre: Universidade Federal do Rio Grande do Sul, 2017. Dissertação de Mestrado em Ciências Farmacêuticas.

        Nahata MC, Loyd V, Allen J. Extemporaneous Drug Formulations. Clinical Therapeutics, 2008; 2112- 2119.

        Costa PQ, Lima JES, Coelho HLL. Prescrição e preparo de medicamentos sem formulação adequada para crianças: um estudo de base hospitalar. Brazilian Journal of Pharmaceutical Sciences, 2009; 57-66.

        Peterlini MAS, Chaud MN, Pedreira MLG. Órfãos de terapia medicamentosa: a administração de medicamentos por via intravenosa em crianças hospitalizadas. Rev Latino-am Enfermagem, 2003; 11(1):88-95.

        Giam JÁ, Mclachilan AJ. Extemporaneous product use in paediatric patients: a systematic review. International Journal of Pharmacy Practice, 2008; 3- 10.

        USP 41. The United States Pharmacopeia. 41. ed. Rockville: United States Pharmacopeia Convention, 2017.

        Allen LV, Popovich NG, Ansel HC. Ansel’s Pharmaceutical Dosage Forms and Drug Delivery Systems. 9. ed. Philadelphia: Lippincott Williams & Wilkins; 2011.

        AOAC INTERNATIONAL, Guidelines for standard method performance requirements – Appendix f. AOAC official methods of analysis, 2016.

        Downloads

        Published

        16-07-2020 — Updated on 12-03-2026

        Versions

        How to Cite

        D’Amore, C. M., Simon, E. de S., & Steppe, M. (2026). Evaluation of Physical-Chemical and Microbiological Stability of Fluconazole Oral Suspensions for Hospital Use. Drug Analytical Research, 4(1), 39–43. https://doi.org/10.22456/2527-2616.103473 (Original work published July 16, 2020)

        Issue

        Section

        ORIGINAL ARTICLES

        Most read articles by the same author(s)

        << < 1 2 

        Similar Articles

        1 2 3 4 5 6 7 8 9 10 > >> 

        You may also start an advanced similarity search for this article.